+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Infusion Therapy Devices Market 2019-2023 - Product Image

Global Infusion Therapy Devices Market 2019-2023

  • ID: 4773709
  • Report
  • Region: Global
  • 149 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 4

FEATURED COMPANIES

  • B. Braun Melsungen AG
  • Becton Dickinson and Co.
  • F. Hoffmann-La Roche Ltd.
  • Fresenius Kabi AG
  • ICU Medical Inc.
  • Medtronic
  • MORE
The growing number of surgical process is one of the critical factors that will trigger the growth of the infusion therapy devices market. Surgical procedures comprise manual and instrumental medical intervention, which are usually performed in ASCs and hospital clinical settings under anesthesia and with the aid of respiratory devices. Surgical procedures can be performed either in inpatient or outpatient settings. The growing number of outpatient and ambulatory surgeries and the increasing number of people with diseases such as cancer contribute to the growth of the global infusion therapy devices market. Infusion therapy devices are an important therapeutic tool to deliver medications continuously in critical care and pain management situations. The number of surgical procedures performed every year worldwide has increased over the last decade due to the rising prevalence of several diseases. Thus, the increase in the number of surgical procedures during the forecast period will drive the growth of the global infusion therapy devices market during the forecast period. Analysts have predicted that the infusion therapy devices market will register a CAGR of 6% by 2023.

Market Overview

Growing aged population and chronic disease prevalence

The increasing life expectancy among people and the prevalence of chronic diseases such as diabetes, cardiovascular, kidney disease, and cancer are contributing to the demand or infusion therapy devices. The number of people with chronic diseases is increasing owing to the sedentary lifestyle, environmental issues, alcohol consumption, lack of physical activity, smoking, and unhealthy eating habits. The aging of the baby boomer generation and increasing prevalence of chronic diseases make the early diagnosis of diseases and the regular monitoring of patients essential to identify, treat, control, and limit the incidence of diseases. Thus, there is a high demand for infusion pumps to provide continuous medication and blood components for critically ill chronic patients. Therefore, the increasing aging of the population and the prevalence of chronic diseases drive the demand for global infusion therapy devices.

High cost of infusion therapy devices

The high cost of infusion therapy devices is one of the major concerns as most patients are unable to afford these devices. With the advances in infusion therapy devices, the cost of devices and treatment is also increasing. The cost includes physician fees, the type of infusion therapy device used, availability of inbuilt features like dose-error reduction software (DERS), and the amount reimbursed for such devices by Mediclaim. The high initial cost of infusion therapy devices, as well as their steep maintenance costs, make them inaccessible and unaffordable in hospitals and primary healthcare centers. Considering all these factors, this is expected to have an adverse impact on the market during the forecast period.

Competitive Landscape

The market appears to be moderately fragmented. The presence of several companies, including B. Braun Melsungen AG and Becton Dickinson and Co. makes the competitive environment quite intense. Factors such as the growing aged population and chronic illness prevalence and the increasing number of surgical procedures will provide significant growth opportunities to infusion therapy devices manufacturers. F. Hoffmann-La Roche Ltd., Fresenius Kabi AG, ICU Medical Inc., Medtronic, and Terumo Corp. are some of the major companies covered in this report.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • B. Braun Melsungen AG
  • Becton Dickinson and Co.
  • F. Hoffmann-La Roche Ltd.
  • Fresenius Kabi AG
  • ICU Medical Inc.
  • Medtronic
  • MORE
PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT
  • Preface
  • Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis
PART 04: MARKET SIZING
  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
PART 06: MARKET SEGMENTATION BY PRODUCT
  • Market segmentation by product
  • Comparison by product
  • Accessories and consumables - Market size and forecast 2018-2023
  • Pumps - Market size and forecast 2018-2023
  • Market opportunity by product
PART 07: MARKET SEGMENTATION BY INFUSION TYPE
  • Market segmentation by infusion type
  • Comparison by infusion type
  • Continuous infusion - Market size and forecast 2018-2023
  • Intermittent infusion - Market size and forecast 2018-2023
  • Infusion-on-demand - Market size and forecast 2018-2023
  • Total parenteral infusion - Market size and forecast 2018-2023
  • Market opportunity by infusion type
PART 08: CUSTOMER LANDSCAPE

PART 09: GEOGRAPHIC LANDSCAPE
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2018-2023
  • Europe - Market size and forecast 2018-2023
  • Asia - Market size and forecast 2018-2023
  • ROW - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity
PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES
  • Market drivers
  • Market challenges
PART 12: MARKET TRENDS
  • Emergence of smart infusion therapy devices
  • Technological advances
  • Increasing consumer preference for disposable infusion pumps
PART 13: VENDOR LANDSCAPE
  • Overview
  • Landscape disruption
PART 14: VENDOR ANALYSIS
  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • B. Braun Melsungen AG
  • Becton Dickinson and Co.
  • F. Hoffmann-La Roche Ltd.
  • Fresenius Kabi AG
  • ICU Medical Inc.
  • Medtronic
  • Terumo Corp.
PART 15: APPENDIX
  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors
PART 16: EXPLORE

List of Exhibits:
Exhibit 01: Global medical devices market
Exhibit 02: Segments of global medical devices market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition - Inclusions and exclusions checklist
Exhibit 06: Market size 2018
Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 09: Five forces analysis 2018
Exhibit 10: Five forces analysis 2023
Exhibit 11: Bargaining power of buyers
Exhibit 12: Bargaining power of suppliers
Exhibit 13: Threat of new entrants
Exhibit 14: Threat of substitutes
Exhibit 15: Threat of rivalry
Exhibit 16: Market condition - Five forces 2018
Exhibit 17: Product - Market share 2018-2023 (%)
Exhibit 18: Comparison by product
Exhibit 19: Accessories and consumables - Market size and forecast 2018-2023 ($ millions)
Exhibit 20: Accessories and consumables - Year-over-year growth 2019-2023 (%)
Exhibit 21: Pumps - Market size and forecast 2018-2023 ($ millions)
Exhibit 22: Pumps - Year-over-year growth 2019-2023 (%)
Exhibit 23: Volumetric pumps - Market size and forecast 2018-2023 ($ millions)
Exhibit 24: Volumetric pumps - Year-over-year growth 2019-2023 (%)
Exhibit 25: Syringe pumps - Market size and forecast 2018-2023 ($ millions)
Exhibit 26: Syringe pumps - Year-over-year growth 2019-2023 (%)
Exhibit 27: Insulin pumps - Market size and forecast 2018-2023 ($ millions)
Exhibit 28: Insulin pumps - Year-over-year growth 2019-2023 (%)
Exhibit 29: Ambulatory pumps - Market size and forecast 2018-2023 ($ millions)
Exhibit 30: Ambulatory pumps - Year-over-year growth 2019-2023 (%)
Exhibit 31: Other pumps - Market size and forecast 2018-2023 ($ millions)
Exhibit 32: Other pumps - Year-over-year growth 2019-2023 (%)
Exhibit 33: Market opportunity by product
Exhibit 34: Infusion type - Market share 2018-2023 (%)
Exhibit 35: Comparison by infusion type
Exhibit 36: Continuous infusion - Market size and forecast 2018-2023 ($ millions)
Exhibit 37: Continuous infusion - Year-over-year growth 2019-2023 (%)
Exhibit 38: Intermittent infusion - Market size and forecast 2018-2023 ($ millions)
Exhibit 39: Intermittent infusion - Year-over-year growth 2019-2023 (%)
Exhibit 40: Infusion-on-demand - Market size and forecast 2018-2023 ($ millions)
Exhibit 41: Infusion-on-demand - Year-over-year growth 2019-2023 (%)
Exhibit 42: Total parenteral infusion - Market size and forecast 2018-2023 ($ millions)
Exhibit 43: Total parenteral infusion - Year-over-year growth 2019-2023 (%)
Exhibit 44: Market opportunity by infusion type
Exhibit 45: Customer landscape
Exhibit 46: Market share by geography 2018-2023 (%)
Exhibit 47: Geographic comparison
Exhibit 48: North America - Market size and forecast 2018-2023 ($ millions)
Exhibit 49: North America - Year-over-year growth 2019-2023 (%)
Exhibit 50: Europe - Market size and forecast 2018-2023 ($ millions)
Exhibit 51: Europe - Year-over-year growth 2019-2023 (%)
Exhibit 52: Asia - Market size and forecast 2018-2023 ($ millions)
Exhibit 53: Asia - Year-over-year growth 2019-2023 (%)
Exhibit 54: ROW - Market size and forecast 2018-2023 ($ millions)
Exhibit 55: ROW - Year-over-year growth 2019-2023 (%)
Exhibit 56: Key leading countries
Exhibit 57: Market opportunity
Exhibit 58: Impact of drivers and challenges
Exhibit 59: Vendor landscape
Exhibit 60: Landscape disruption
Exhibit 61: Vendors covered
Exhibit 62: Vendor classification
Exhibit 63: Market positioning of vendors
Exhibit 64: B. Braun Melsungen AG - Vendor overview
Exhibit 65: B. Braun Melsungen AG - Business segments
Exhibit 66: B. Braun Melsungen AG - Organizational developments
Exhibit 67: B. Braun Melsungen AG - Geographic focus
Exhibit 68: B. Braun Melsungen AG - Segment focus
Exhibit 69: B. Braun Melsungen AG - Key offerings
Exhibit 70: Becton Dickinson and Co. - Vendor overview
Exhibit 71: Becton Dickinson and Co. - Business segments
Exhibit 72: Becton Dickinson and Co. - Organizational developments
Exhibit 73: Becton Dickinson and Co. - Geographic focus
Exhibit 74: Becton Dickinson and Co. - Segment focus
Exhibit 75: Becton Dickinson and Co. - Key offerings
Exhibit 76: F. Hoffmann-La Roche Ltd. - Vendor overview
Exhibit 77: F. Hoffmann-La Roche Ltd. - Business segments
Exhibit 78: F. Hoffmann-La Roche Ltd. - Organizational developments
Exhibit 79: F. Hoffmann-La Roche Ltd. - Geographic focus
Exhibit 80: F. Hoffmann-La Roche Ltd. - Segment focus
Exhibit 81: F. Hoffmann-La Roche Ltd. - Key offerings
Exhibit 82: Fresenius Kabi AG - Vendor overview
Exhibit 83: Fresenius Kabi AG - Business segments
Exhibit 84: Fresenius Kabi AG - Organizational developments
Exhibit 85: Fresenius Kabi AG - Geographic focus
Exhibit 86: Fresenius Kabi AG - Segment focus
Exhibit 87: Fresenius Kabi AG - Key offerings
Exhibit 88: ICU Medical Inc. - Vendor overview
Exhibit 89: ICU Medical Inc. - Product segments
Exhibit 90: ICU Medical Inc. - Organizational developments
Exhibit 91: ICU Medical Inc. - Geographic focus
Exhibit 92: ICU Medical Inc. - Segment focus
Exhibit 93: ICU Medical Inc. - Key offerings
Exhibit 94: Medtronic - Vendor overview
Exhibit 95: Medtronic - Business segments
Exhibit 96: Medtronic - Organizational developments
Exhibit 97: Medtronic - Geographic focus
Exhibit 98: Medtronic - Segment focus
Exhibit 99: Medtronic - Key offerings
Exhibit 100: Terumo Corp. - Vendor overview
Exhibit 101: Terumo Corp. - Business segments
Exhibit 102: Terumo Corp. - Organizational developments
Exhibit 103: Terumo Corp. - Geographic focus
Exhibit 104: Terumo Corp. - Segment focus
Exhibit 105: Terumo Corp. - Key offerings
Exhibit 106: Validation techniques employed for market sizing
Exhibit 107: Definition of market positioning of vendors
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4

FEATURED COMPANIES

  • B. Braun Melsungen AG
  • Becton Dickinson and Co.
  • F. Hoffmann-La Roche Ltd.
  • Fresenius Kabi AG
  • ICU Medical Inc.
  • Medtronic
  • MORE
The following companies are recognised as the key players in the global infusion therapy devices market: B. Braun Melsungen AG, Becton Dickinson and Co., F. Hoffmann-La Roche Ltd., Fresenius Kabi AG, ICU Medical Inc., Medtronic, and Terumo Corp.

Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the increasing consumer preference for disposable infusion pumps.”

According to the report, one of the major drivers in this market is the increasing use of infusion therapy devices in home care settings.

Further, the report states that one of the major factors hindering the growth of this market is the high cost of infusion therapy devices.

The study was conducted using an objective combination of primary and secondary information, including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 4
  • B. Braun Melsungen AG
  • Becton Dickinson and Co.
  • F. Hoffmann-La Roche Ltd.
  • Fresenius Kabi AG
  • ICU Medical Inc.
  • Medtronic
  • Terumo Corp.
Note: Product cover images may vary from those shown
Adroll
adroll